Preliminary scientific tests reveal conolidine may inhibit particular ion channels, lowering neuronal excitability and limiting pain signals. This mechanism is especially related in neuropathic soreness, in which abnormal signaling leads to persistent soreness. Also, conolidine seems to influence G protein-coupled receptor (GPCR) pathways integral to soreness perception. Computational... https://keithr849dlr3.wikibyby.com/user